Karim Maloum

6PUBLICATIONS
18CO-AUTHORS
Molecular targetsHaematological tumoursMedical mycologyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jan 07, 2026
Olaparib sensitizes chronic lymphocytic leukemia to BTK- and BCL2-targeted therapies via PARP1-independent mitochondrial metabolic dysfunction.

Marianne Ayoub, Casilda Hitier, Léa Dehgane

|Dec 09, 2025
REL overexpression and sustained NF-κB signaling associated with 2p gain induce resistance to BTK inhibitors in Chronic Lymphocytic Leukemia.

Léa Dehgane, Eliane Mallet, Constance Brasseur

|Jan 23, 2024
Acute myeloid leukemia with misleading cytology.

Mayssa Gaaloul, Madalina Uzunov, Karim Maloum

|Dec 06, 2023
ACOX1-mediated peroxisomal fatty acid oxidation contributes to metabolic reprogramming and survival in chronic lymphocytic leukemia.

Mariana Tannoury, Marianne Ayoub, Léa Dehgane

|Dec 06, 2021
CAR T-cell therapy in primary central nervous system lymphoma: the clinical experience of the French LOC network.

Marion Alcantara, Caroline Houillier, Marie Blonski

|Mar 05, 2019
Automated differential white blood cell count and cytological analysis can detect near-tetraploid cells in chronic lymphoproliferative disorders.

Catherine Settegrana, Elise Chapiro, Corinne Frere

Pageof 1

Frequent Collaborators

4 joint publications

Elise Chapiro

3 joint publications

Santos A Susin

3 joint publications

Delphine Garnier

2 joint publications

Damien Roos-Weil